COVID-19 accelerated trends that were already underway in gastroenterology. Health systems and insurance companies have become more powerful. Private equity has fueled massive consolidation. Colon cancer screening options have expanded. AI has embedded itself into endoscopy. Finally, patients have become demanding consumers.
You can’t rely on pre-COVID business models for growth.
There are two ways that we can work with you:
1) Growth Strategy: Explore which consolidation strategy is right for you: private equity, strategic and hospital partnerships.
2) Digitization Strategy: Develop a digital health plan to stay relevant in the future — from apps to automations and virtual reality.
We are in the midst of a massive wave of consolidation fueled by private equity (PE). In the last two years, gastroenterologists started new PE-led platforms, joined existing PE platforms, partnered with regional hospitals, and independently consolidated with local groups. But, how do you know which approach is right for you?
Instead of being led by industry forces, what if you approached growth strategy on your terms? Save time and money by hiring us to methodically approach growth. With the help of advanced tools, we’ll help you and your team develop a plan that’s right for you.
Digital transformation is coming to gastroenterology in the form of DNA testing, AI, the microbiome, virtual reality and other exponential technologies. How do you benefit from these tools of disruption before they disrupt you?